Interrelationship Between Markers of Oxidative Stress, Inflammation and Hematological Parameters Among Preeclamptic Nigerian Women
Overview
Authors
Affiliations
BACKGROUND Preeclampsia is a multifaceted pregnancy-related disorder affecting women and fetuses. A link between preeclampsia, oxidative stress, and inflammation has been suggested. This study evaluated the interrelationship between biomarkers of oxidative stress, inflammation, and hematological parameters among preeclamptic Nigerian women. MATERIAL AND METHODS A cross-sectional study was conducted among 49 preeclamptic and 50 normotensive healthy pregnant women. Blood samples were obtained after 20-week gestation in all participants. Levels of superoxide dismutase (SOD), catalase, glutathione (GSH), malonaldehyde (MDA), total protein, high-sensitivity C-reactive protein (hs-CRP), and cardiac-specific troponin I (cTnI) were determined by spectrophotometric and ELISA techniques. FBC, prothrombin time, and activated partial thromboplastin time were determined using an auto-analyzer, Quick's one-stage, and Proctor's and Rappaport's modification methods, respectively. RESULTS The mean SOD (0.051±0.050 vs. 0.073±0.047, p 0.029), catalase (2.62±1.93 vs. 8.48±4.40, p<0.001), GSH (49.05±17.57 vs. 187.10±56.07 p<0.001), platelet (127.63±89.75 vs. 267.16±212.82, p<0.001 were lower in preeclampsia. MDA (7.16±5.00 vs. 2.91±2.66, p<0.001), cTnI (0.46±0.31 vs. 0.13±0.14 p<0.001), PT (19.36±4.06 vs. 13.45±1.97 p<0.001), APTT (45.53±2.92 vs. 37.49±4.99; p<0.001) were higher in preeclampsia. Negative associations between SOD and MDA (r -0.527 p<0.001), CAT and MDA (r -0.469, p 0.001) and positive associations between catalase and hs-CRP (r 0.844, p 0.029), RBC and HB (r 0.442, p 0.001), platelet, and SOD (r 0.353, p 0.013) were observed among preeclamptic volunteers. CONCLUSIONS Preeclampsia is associated with oxidative stress, derangement of hematological and coagulation homeostasis, as well as deleterious effects on the cardiovascular system.
Alemayehu E, Mohammed O, Belete M, Mulatie Z, Debash H, Gedefie A BMC Pregnancy Childbirth. 2024; 24(1):354.
PMID: 38741046 PMC: 11092070. DOI: 10.1186/s12884-024-06543-7.
Dawoud A, Youness R, Nafea H, Manie T, Bourquin C, Szabo C Cancer Cell Int. 2024; 24(1):136.
PMID: 38627665 PMC: 11020979. DOI: 10.1186/s12935-024-03317-1.
Jin P, Ding N, Dai J, Liu X, Mao P Clin Appl Thromb Hemost. 2024; 30:10760296241238015.
PMID: 38529627 PMC: 10964434. DOI: 10.1177/10760296241238015.
Jimenez-Osorio A, Carreon-Torres E, Correa-Solis E, Angel-Garcia J, Arias-Rico J, Jimenez-Garza O Antioxidants (Basel). 2023; 12(10).
PMID: 37891973 PMC: 10604737. DOI: 10.3390/antiox12101894.
Jin P, Ding N, Dai J, Liu X, Mao P Heliyon. 2023; 9(7):e17983.
PMID: 37496928 PMC: 10366388. DOI: 10.1016/j.heliyon.2023.e17983.